|
DRAM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.534600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.089050E-01 |
| Normal-vs-Stage2 |
4.296600E-01 |
| Normal-vs-Stage3 |
9.098600E-01 |
| Normal-vs-Stage4 |
9.361000E-01 |
| Stage1-vs-Stage2 |
3.589900E-02 |
| Stage1-vs-Stage3 |
1.046580E-01 |
| Stage1-vs-Stage4 |
1.228360E-01 |
| Stage2-vs-Stage3 |
5.362400E-01 |
| Stage2-vs-Stage4 |
4.009800E-01 |
| Stage3-vs-Stage4 |
8.501800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.893200E-01 |
| Normal-vs-AfricanAmerican |
3.475700E-02 |
| Normal-vs-Asian |
6.941800E-01 |
| Caucasian-vs-AfricanAmerican |
5.077600E-02 |
| Caucasian-vs-Asian |
6.216200E-01 |
| AfricanAmerican-vs-Asian |
1.608430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.203400E-01 |
| Normal-vs-Female |
4.053200E-01 |
| Male-vs-Female |
6.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.303000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.304800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.764000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.327000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.437600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.056600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.488400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.781000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.028200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.181200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.648300E-02 |
| Normal-vs-Grade 2 |
8.135200E-01 |
| Normal-vs-Grade 3 |
3.890400E-01 |
| Normal-vs-Grade 4 |
9.929400E-01 |
| Grade 1-vs-Grade 2 |
3.057800E-02 |
| Grade 1-vs-Grade 3 |
7.516400E-02 |
| Grade 1-vs-Grade 4 |
3.440300E-02 |
| Grade 2-vs-Grade 3 |
4.088200E-01 |
| Grade 2-vs-Grade 4 |
8.221400E-01 |
| Grade 3-vs-Grade 4 |
4.006600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.718800E-01 |
| Normal-vs-ccB subtype |
7.433400E-01 |
| ccA subtype-vs-ccB subtype |
1.063050E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.779000E-01 |
| Normal-vs-N1 |
3.373000E-01 |
| N0-vs-N1 |
2.507600E-01 |
|
|
